Call Today: 1-888-788-5353

Blog Category: FDA

The U.S. Food and Drug Administration (FDA) hints that it may increase its nicotine regulations after electronic cigarette enterprise, Juul Labs, Inc. hooked a generation on vaping.  Last month, the FDA ordered all currently marketed Juul products to be removed from the U.S. market. The agency determined there is not enough evidence to “assess the… read more

Post Categories: FDA, Merchant Monitoring, Merchant Risk
Nutraceuticals Claims Guide

When onboarding a nutraceutical merchant, how do you know which claims are compliant versus which claims cross the line? Obviously, a dietary supplement cannot be marketed with claims to miraculously cure COVID-19, but can it be marketed to relieve joint pain? Or reduce inflammation? What if the merchant’s website is claim-free, but its social media includes claims to help treat hypertension? Can a merchant… read more

The US CBD market (which is projected to hit $16 billion by 2025) currently operates without significant federal oversight. Indeed, some describe the industry as the “wild west”—a regulatory-free zone that puts consumer safety at risk. On Friday, the FDA grasped the regulatory reins: the agency held a nearly 10-hour public hearing on cannabis-derived products…. read more

See how our solutions can help you.

Call Today:

1-888-788-5353

us